These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24637124)

  • 1. Concomitant pathologies among a spectrum of parkinsonian disorders.
    Dugger BN; Adler CH; Shill HA; Caviness J; Jacobson S; Driver-Dunckley E; Beach TG;
    Parkinsonism Relat Disord; 2014 May; 20(5):525-9. PubMed ID: 24637124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.
    Hansen D; Ling H; Lashley T; Foley JA; Strand C; Eid TM; Holton JL; Warner TT
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):143-156. PubMed ID: 32720329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral amyloid angiopathy in Lewy body disease.
    Jellinger KA; Attems J
    J Neural Transm (Vienna); 2008; 115(3):473-82. PubMed ID: 18301958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of cerebral atrophy differ in different degenerative pathologies.
    Whitwell JL; Jack CR; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Ferman TJ; Dickson DW; Josephs KA
    Brain; 2007 Apr; 130(Pt 4):1148-58. PubMed ID: 17347250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of falls in postmortem-confirmed parkinsonian disorders.
    Wenning GK; Ebersbach G; Verny M; Chaudhuri KR; Jellinger K; McKee A; Poewe W; Litvan I
    Mov Disord; 1999 Nov; 14(6):947-50. PubMed ID: 10584668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders.
    Müller J; Wenning GK; Verny M; McKee A; Chaudhuri KR; Jellinger K; Poewe W; Litvan I
    Arch Neurol; 2001 Feb; 58(2):259-64. PubMed ID: 11176964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.
    Dugger BN; Davis K; Malek-Ahmadi M; Hentz JG; Sandhu S; Beach TG; Adler CH; Caselli RJ; Johnson TA; Serrano GE; Shill HA; Belden C; Driver-Dunckley E; Caviness JN; Sue LI; Jacobson S; Powell J; Sabbagh MN
    BMC Neurol; 2015 Aug; 15():146. PubMed ID: 26289075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series.
    Geut H; Hepp DH; Foncke E; Berendse HW; Rozemuller JM; Huitinga I; van de Berg WDJ
    Acta Neuropathol Commun; 2020 Mar; 8(1):39. PubMed ID: 32216828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological substrates of mental dysfunction in Lewy body disease: an update.
    Jellinger KA
    J Neural Transm Suppl; 2000; 59():185-212. PubMed ID: 10961431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
    Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
    Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vascular risk factors and vascular neuropathology in subjects with autopsy-confirmed dementia with Lewy bodies.
    Chen ZC; Gan J; Yang Y; Meng Q; Han J; Ji Y
    Int J Geriatr Psychiatry; 2022 Mar; 37(3):. PubMed ID: 35128731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Freezing of gait in postmortem-confirmed atypical parkinsonism.
    Müller J; Seppi K; Stefanova N; Poewe W; Litvan I; Wenning GK
    Mov Disord; 2002 Sep; 17(5):1041-5. PubMed ID: 12360556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy.
    Shill HA; Zhang N; Driver-Dunckley E; Mehta S; Adler CH; Beach TG
    Mov Disord; 2021 Jul; 36(7):1700-1704. PubMed ID: 33755262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuropathological landscape of small vessel disease and Lewy pathology in a cohort of Hispanic and non-Hispanic White decedents with Alzheimer disease.
    Wang HP; Scalco R; Saito N; Beckett L; Nguyen ML; Huie EZ; Honig LS; DeCarli C; Rissman RA; Teich AF; Mungas DM; Jin LW; Dugger BN
    Acta Neuropathol Commun; 2024 May; 12(1):81. PubMed ID: 38790074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy.
    Beach TG; Sue LI; Scott S; Intorcia AJ; Walker JE; Arce RA; Glass MJ; Borja CI; Cline MP; Hemmingsen SJ; Qiji S; Stewart A; Martinez KN; Krupp A; McHattie R; Mariner M; Lorenzini I; Kuramoto A; Long KE; Tremblay C; Caselli RJ; Woodruff BK; Rapscak SZ; Belden CM; Goldfarb D; Choudhury P; Driver-Dunckley ED; Mehta SH; Sabbagh MN; Shill HA; Atri A; Adler CH; Serrano GE
    J Neuropathol Exp Neurol; 2023 May; 82(6):457-466. PubMed ID: 37071794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study.
    Jellinger KA
    J Neural Transm Suppl; 2007; (72):91-104. PubMed ID: 17982882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.
    Boeve BF; Silber MH; Ferman TJ; Lucas JA; Parisi JE
    Mov Disord; 2001 Jul; 16(4):622-30. PubMed ID: 11481685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.